drugset / Trial / NCT00423124

Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies

NCT00423124

Phase 1/2 Completed 57 enrolled AGC Biologics S.p.A.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study is to obtain immune reconsitutuion as well as reduction of infective episodes and disease relapse in patient with haematological malignancies who underwent SCT(and subsequent T lymphocytes infusions) and selectively controlling GvHD.

Timeline

Start
2002-07
Primary completion
2011-12
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject HSV-Tk Cell therapy 1e+06 cells/kg
Subject HSV-Tk Cell therapy 1e+07 cells/kg